APA (7th ed.) Citation

JL, G., T, D., & SK, V. (2026). Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications. Pain and therapy, 15(3), 751. https://doi.org/10.1007/s40122-026-00835-w

Chicago Style (17th ed.) Citation

JL, Green, Dailey-Govoni T, and Vosburg SK. "Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications." Pain and Therapy 15, no. 3 (2026): 751. https://doi.org/10.1007/s40122-026-00835-w.

MLA (9th ed.) Citation

JL, Green, et al. "Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications." Pain and Therapy, vol. 15, no. 3, 2026, p. 751, https://doi.org/10.1007/s40122-026-00835-w.